Connexin40 abnormalities and atrial fibrillation in the human heart

Current Therapeutic Research - Clinical and Experimental

Volumn 76, Issue , 2014, Pages 159-168

  Gemel, Joanna ^a   Levy, Andrew E ^a   Simon, Adria R ^a,d   Bennett, Katherine B ^a   Ai, Xun ^b   Akhter, Shahab ^c   Beyer, Eric C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Atrial fibrillation; Connexin; Connexin40; Gap junction

Indexed keywords

CONNEXIN 40; CONNEXIN 43; GENOMIC DNA; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; CADHERIN; CDH2 PROTEIN, HUMAN; GAP JUNCTION PROTEIN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC PATIENT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA POLYMORPHISM; EXTRACELLULAR SPACE; FEMALE; GAP JUNCTION; GENE MUTATION; GENOTYPE; HEART ATRIUM; HEART ATRIUM APPENDAGE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE HOMOGENATE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ATRIAL FIBRILLATION; CADHERINS; CASE-CONTROL STUDIES; CONNEXIN 43; CONNEXINS; FEMALE; GAP JUNCTIONS; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84919787810     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.08.021     Document Type: Article

References (40)

1. Allessie M.A., Boyden P.A., Camm A.J., Kleber A.G., Lab M.J., Legato M.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001, 103:769-777.
2. Iwasaki Y.K., Nishida K., Kato T., Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 2011, 124:2264-2274.
3. Spach M.S., Starmer C.F. Altering the topology of gap junctions: a major therapeutic target for atrial fibrillation. Cardiovasc Res 1995, 30:337-344.
4. Saffitz J.E., Kanter H.L., Green K.G., Tolley T.K., Beyer E.C. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 1994, 74:1065-1070.
5. Lin X., Gemel J., Glass A., Zemlin C.W., Beyer E.C., Veenstra R.D. Connexin40 and connexin43 determine gating properties of atrial gap junction channels. J Mol Cell Cardiol 2010, 48:238-245.
6. Kato T., Iwasaki Y.K., Nattel S. Connexins and atrial fibrillation: filling in the gaps. Circulation 2012, 125:203-206.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
8. Bolte S., Cordelieres F.P. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006, 224:213-232.
9. Kanagaratnam P., Rothery S., Patel P., Severs N.J., Peters N.S. Relative expression of immunolocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 2002, 39:116-123.
10. Wilhelm M., Kirste W., Kuly S., Amann K., Neuhuber W., Weyand M., et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ 2006, 15:30-37.
11. Dolber P.C., Beyer E.C., Junker J.L., Spach M.S. Distribution of gap junctions in dog and rat ventricle studied with a double-label technique. J Mol Cell Cardiol 1992, 24:1443-1457.
12. Pandya K., Kim H.S., Smithies O. Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc Natl Acad Sci U S A 2006, 103:16864-16869.
13. Glukhov A.V., Fedorov V.V., Kalish P.W., Ravikumar V.K., Lou Q., Janks D., et al. Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy. Circulation 2012, 125:1835-1847.
14. Gollob M.H., Jones D.L., Krahn A.D., Danis L., Gong X.Q., Shao Q., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006, 354:2677-2688.
15. Yang Y.-Q., Liu X., Zhang X.L., Wang X.H., Tan H.W., Shi H.F., et al. Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 2010, 12:1421-1427.
16. Sun Y., Yang Y.Q., Gong X.Q., Wang X.H., Li R.G., Tan H.W., et al. Novel germline GJA5/connexin40 mutations associated with lone atrial fibrillation impair gap junctional intercellular communication. Hum Mutat 2013, 34:603-609.
17. Firouzi M., Ramanna H., Kok B., Jongsma H.J., Koeleman B.P., Doevendans P.A., et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004, 95:e29-e33.
18. Firouzi M., Kok B., Spiering W., Busjahn A., Bezzina C.R., Ruijter J.M., et al. Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men. J Hypertens 2006, 24:325-330.
19. Wirka R.C., Gore S., Van Wagoner D.R., Arking D.E., Lubitz S.A., Lunetta K.L., et al. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2011, 4:87-93.
20. Pfenniger A., van der Laan S.W., Foglia B., Dunoyer-Geindre S., Haefliger J.A., Winnik S., et al. Lack of association between connexin40 polymorphisms and coronary artery disease. Atherosclerosis 2012, 222:148-153.
21. Chaldoupi S.M., Hubens L.E., Smit Duijzentkunst D.A., van S.L., Bierhuizen M.F., van Aarnhem E.E., et al. Reduced connexin40 protein expression in the right atrial appendage of patients bearing the minor connexin40 allele (-44G→A). Europace 2012, 14:1199-1205.
22. Beauchamp P., Yamada K.A., Baertschi A.J., Green K., Kanter E.M., Saffitz J.E., et al. Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardiomyocytes. Circ Res 2006, 99:1216-1224.
23. Dhillon P.S., Chowdhury R.A., Patel P.M., Jabr R., Momin A.U., Vecht J., et al. The relationship between connexin expression and gap junction resistivity in human atrial myocardium. Circ Arrhythm Electrophysiol 2014, 7:321-329.
24. Polontchouk L., Haefliger J.A., Ebelt B., Schaefer T., Stuhlmann D., Mehlhorn U., et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001, 38:883-891.
25. Nao T., Ohkusa T., Hisamatsu Y., Inoue N., Matsumoto T., Yamada J., et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 2003, 91:678-683.
26. Kostin S., Klein G., Szalay Z., Hein S., Bauer E.P., Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002, 54:361-379.
27. van der Velden H.M., van K.M., Wijffels M.C., van Z.M., Groenewegen W.A., Allessie M.A., et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 1998, 9:596-607.
28. van der Velden H.M., Ausma J., Rook M.B., Hellemons A.J., van Veen T.A., Allessie M.A., et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000, 46:476-486.
29. Shi H.F., Yang J.F., Wang Q., Li R.G., Xu Y.J., Qu X.K., et al. Prevalence and spectrum of GJA5 mutations associated with lone atrial fibrillation. Mol Med Rep 2013, 7:767-774.
30. Patel D., Gemel J., Xu Q., Simon A.R., Lin X., Matiukas A., et al. Atrial fibrillation-associated connexin40 mutants make hemichannels and synergistically form gap junction channels with novel properties. FEBS Lett 2014, 588:1458-1464.
31. Gemel J., Simon A.R., Patel D., Xu Q., Matiukas A., Veenstra R.D., et al. Degradation of a connexin40 mutant linked to atrial fibrillation is accelerated. J Mol Cell Cardiol 2014, 74:330-339.
32. Tchou G.D., Wirka R.C., Van Wagoner D.R., Barnard J., Chung M.K., Smith J.D. Low prevalence of connexin-40 gene variants in atrial tissues and blood from atrial fibrillation subjects. BMC Med Genet 2012, 13:102.
33. Verheule S., van Batenburg C.A., Coenjaerts F.E., Kirchhoff S., Willecke K., Jongsma H.J. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J Cardiovasc Electrophysiol 1999, 10:1380-1389.
34. Bagwe S., Berenfeld O., Vaidya D., Morley G.E., Jalife J. Altered right atrial excitation and propagation in connexin40 knockout mice. Circulation 2005, 112:2245-2253.
35. Alcolea S., Jarry-Guichard T., de Bakker J., Gonzalez D., Lamers W., Coppen S., et al. Replacement of connexin40 by connexin45 in the mouse: impact on cardiac electrical conduction. Circ Res 2004, 94:100-109.
36. Lubkemeier I., Andrie R., Lickfett L., Bosen F., Stockigt F., Dobrowolski R., et al. The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice. J Mol Cell Cardiol 2013, 65C:19-32.
37. Hagendorff A., Schumacher B., Kirchhoff S., Luderitz B., Willecke K. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999, 99:1508-1515.
38. Bevilacqua L.M., Simon A.M., Maguire C.T., Gehrmann J., Wakimoto H., Paul D.L., et al. A targeted disruption in Connexin40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol 2000, 4:459-567.
39. Christophersen I.E., Holmegard H.N., Jabbari J., Sajadieh A., Haunso S., Tveit A., et al. Rare variants in GJA5 are associated with early-onset lone atrial fibrillation. Can J Cardiol 2013, 29:111-116.
40. Chaldoupi S.M., Loh P., Hauer R.N., de Bakker J.M., van Rijen H.V. The role of connexin40 in atrial fibrillation. Cardiovasc Res 2009, 84:15-23.